Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization.
Identifieur interne : 000B06 ( PubMed/Checkpoint ); précédent : 000B05; suivant : 000B07Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization.
Auteurs : Ya-Li Sang ; Wei-Ming Zhang [République populaire de Chine] ; Peng-Cheng Lv ; Hai-Liang Zhu [République populaire de Chine]Source :
- Current topics in medicinal chemistry [ 1873-4294 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Indoles.
- Humains, Polymérisation, Prolifération cellulaire, Tubuline.
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Tubulin.
- chemical , pharmacology : Indoles.
- drug effects : Cell Proliferation.
- Humans, Polymerization.
Abstract
Indole is a potential lead for drug design which has been found in numerous pharmaceutically important compounds due to its medicinal properties, such as anti-tumor, anti-bacterial, anti-virus and anti-inflammatory. In the last decade, interfering with microtubule polymerization, a potential orientation to cause cell cycle arrest and apoptosis has become a promising method for cancer therapy. Thus, indole-based agents capable to modulate the microtubule assembly have gained considerable interest among scientists. This review describes the synthesis, bioactivities and SARs of indole-based agents targeting tubulin polymerization during the past decade.
DOI: 10.2174/1568026616666160530154812
PubMed: 27237326
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27237326Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization.</title>
<author><name sortKey="Sang, Ya Li" sort="Sang, Ya Li" uniqKey="Sang Y" first="Ya-Li" last="Sang">Ya-Li Sang</name>
</author>
<author><name sortKey="Zhang, Wei Ming" sort="Zhang, Wei Ming" uniqKey="Zhang W" first="Wei-Ming" last="Zhang">Wei-Ming Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing 210042, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing 210042</wicri:regionArea>
<wicri:noRegion>Nanjing 210042</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lv, Peng Cheng" sort="Lv, Peng Cheng" uniqKey="Lv P" first="Peng-Cheng" last="Lv">Peng-Cheng Lv</name>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210046, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210046</wicri:regionArea>
<wicri:noRegion>Nanjing 210046</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27237326</idno>
<idno type="pmid">27237326</idno>
<idno type="doi">10.2174/1568026616666160530154812</idno>
<idno type="wicri:Area/PubMed/Corpus">000C46</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C46</idno>
<idno type="wicri:Area/PubMed/Curation">000C46</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C46</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B06</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B06</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization.</title>
<author><name sortKey="Sang, Ya Li" sort="Sang, Ya Li" uniqKey="Sang Y" first="Ya-Li" last="Sang">Ya-Li Sang</name>
</author>
<author><name sortKey="Zhang, Wei Ming" sort="Zhang, Wei Ming" uniqKey="Zhang W" first="Wei-Ming" last="Zhang">Wei-Ming Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing 210042, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing 210042</wicri:regionArea>
<wicri:noRegion>Nanjing 210042</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lv, Peng Cheng" sort="Lv, Peng Cheng" uniqKey="Lv P" first="Peng-Cheng" last="Lv">Peng-Cheng Lv</name>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210046, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210046</wicri:regionArea>
<wicri:noRegion>Nanjing 210046</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Current topics in medicinal chemistry</title>
<idno type="eISSN">1873-4294</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cell Proliferation (drug effects)</term>
<term>Humans</term>
<term>Indoles (pharmacology)</term>
<term>Polymerization</term>
<term>Tubulin (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term>
<term>Indoles (pharmacologie)</term>
<term>Polymérisation</term>
<term>Prolifération cellulaire ()</term>
<term>Tubuline ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Tubulin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Indoles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Proliferation</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Indoles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Polymerization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Polymérisation</term>
<term>Prolifération cellulaire</term>
<term>Tubuline</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Indole is a potential lead for drug design which has been found in numerous pharmaceutically important compounds due to its medicinal properties, such as anti-tumor, anti-bacterial, anti-virus and anti-inflammatory. In the last decade, interfering with microtubule polymerization, a potential orientation to cause cell cycle arrest and apoptosis has become a promising method for cancer therapy. Thus, indole-based agents capable to modulate the microtubule assembly have gained considerable interest among scientists. This review describes the synthesis, bioactivities and SARs of indole-based agents targeting tubulin polymerization during the past decade.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27237326</PMID>
<DateCompleted><Year>2017</Year>
<Month>02</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>09</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4294</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>17</Volume>
<Issue>2</Issue>
<PubDate><Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>Current topics in medicinal chemistry</Title>
<ISOAbbreviation>Curr Top Med Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization.</ArticleTitle>
<Pagination><MedlinePgn>120-137</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Indole is a potential lead for drug design which has been found in numerous pharmaceutically important compounds due to its medicinal properties, such as anti-tumor, anti-bacterial, anti-virus and anti-inflammatory. In the last decade, interfering with microtubule polymerization, a potential orientation to cause cell cycle arrest and apoptosis has become a promising method for cancer therapy. Thus, indole-based agents capable to modulate the microtubule assembly have gained considerable interest among scientists. This review describes the synthesis, bioactivities and SARs of indole-based agents targeting tubulin polymerization during the past decade.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sang</LastName>
<ForeName>Ya-Li</ForeName>
<Initials>YL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Wei-Ming</ForeName>
<Initials>WM</Initials>
<AffiliationInfo><Affiliation>Nanjing Institute for the Comprehensive Utilization of Wild Plant, Nanjing 210042, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lv</LastName>
<ForeName>Peng-Cheng</ForeName>
<Initials>PC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Hai-Liang</ForeName>
<Initials>HL</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210046, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United Arab Emirates</Country>
<MedlineTA>Curr Top Med Chem</MedlineTA>
<NlmUniqueID>101119673</NlmUniqueID>
<ISSNLinking>1568-0266</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014404">Tubulin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058105" MajorTopicYN="N">Polymerization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>12</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>03</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>03</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>5</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>5</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27237326</ArticleId>
<ArticleId IdType="pii">CTMC-EPUB-76077</ArticleId>
<ArticleId IdType="doi">10.2174/1568026616666160530154812</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Lv, Peng Cheng" sort="Lv, Peng Cheng" uniqKey="Lv P" first="Peng-Cheng" last="Lv">Peng-Cheng Lv</name>
<name sortKey="Sang, Ya Li" sort="Sang, Ya Li" uniqKey="Sang Y" first="Ya-Li" last="Sang">Ya-Li Sang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Wei Ming" sort="Zhang, Wei Ming" uniqKey="Zhang W" first="Wei-Ming" last="Zhang">Wei-Ming Zhang</name>
</noRegion>
<name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B06 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000B06 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:27237326 |texte= Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27237326" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |